Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page
- Check7 days agoChange DetectedFooter revision tag updated from v3.5.0 to v3.5.2; the previous revision tag is no longer displayed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating a minor site update.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing v3.4.2; this is a minor site maintenance update that does not affect study information.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.4.2 to the site. Removed older notices including the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a government funding notice at the top of the page and updated the site version to v3.4.1, replacing the previous v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedShow glossary added, revision updated to v3.4.0, and labels updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with capitalization changes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.